Eugenia Girda, MD(@EugeniaGirda) 's Twitter Profileg
Eugenia Girda, MD

@EugeniaGirda

Gynecologic Oncologist at Rutgers Cancer Institute of New Jersey. Clinical trials/ developmental therapeutics.

ID:1328788604630478853

calendar_today17-11-2020 19:54:35

163 Tweets

234 Followers

184 Following

Eugenia Girda, MD(@EugeniaGirda) 's Twitter Profile Photo

Concurrent Immunotherapy and Chemoradiation Improve Survival in Cervical Cancer: A Review of the Evidence | ASCO Daily News dailynews.ascopubs.org/do/concurrent-…

account_circle
Eugenia Girda, MD(@EugeniaGirda) 's Twitter Profile Photo

Very interesting results of Duo-E reporting significant benefit in survival of Durvalumab in dMMR group and enhanced benefit of Olaparib with Durvalumab in pMMR group. Is 4 drug regimen the next standard of therapy for pMMR?

Very interesting results of Duo-E reporting significant benefit in survival of Durvalumab in dMMR group and enhanced benefit of Olaparib with Durvalumab in pMMR group. Is 4 drug regimen the next standard of therapy for pMMR? #endometrialcancer
account_circle
Eugenia Girda, MD(@EugeniaGirda) 's Twitter Profile Photo

Indeed, one step closer to the first tumor agnostic ADC approval. Excited to be able to offer it to our HER2 - positive cervical, ovarian and uterine patients.

account_circle
IGCS(@IGCSociety) 's Twitter Profile Photo

January is

If you'd like to join us in spreading awareness, you can utilize our social media toolkit with images and facts driving awareness about cervical cancer and dispelling common myths about HPV and the vaccine.

➡️ igcs.org/cervical-cance…

January is #CervicalCancerAwarenessMonth If you'd like to join us in spreading awareness, you can utilize our social media toolkit with images and facts driving awareness about cervical cancer and dispelling common myths about HPV and the vaccine. ➡️ igcs.org/cervical-cance…
account_circle
CancerTherapyAdvisor(@CancerTherAdvsr) 's Twitter Profile Photo

Adding HIPEC to interval cytoreductive surgery improves long-term outcomes in patients with stage III epithelial . Published in The Lancet Oncology. brnw.ch/21wD5yo

account_circle
RutgersCancerInstNJ(@RutgersCancer) 's Twitter Profile Photo

We are changing the face of cancer care and cancer research in the state of with the state's first freestanding cancer hospital.

Learn more at cinj.org/about-cinj/jac…

RutgersCancerInstNJ RWJBarnabas DEVCO ers

We are changing the face of cancer care and cancer research in the state of #NewJersey with the state's first freestanding cancer hospital. Learn more at cinj.org/about-cinj/jac… @RutgersCancer @RWJBarnabas @NBDEVCO #cancercare #cancercareers
account_circle
National Cancer Institute(@theNCI) 's Twitter Profile Photo

If all women were to get vaccines, potentially two-thirds of cervical cancers could be prevented worldwide. Learn about the history and discovery of HPV . cancer.gov/research/progr…

If all women were to get #HPV vaccines, potentially two-thirds of cervical cancers could be prevented worldwide. Learn about the history and discovery of HPV #vaccines. cancer.gov/research/progr… #NIAM23
account_circle
Eugenia Girda, MD(@EugeniaGirda) 's Twitter Profile Photo

Excellent news for locally advanced cervical cancer, where addition of pembrolizumab to cis RT improved PFS. Awaiting to see data, PD-l1 status and ultimately OS data.
merck.com/news/merck-ann…

account_circle
Eugenia Girda, MD(@EugeniaGirda) 's Twitter Profile Photo

Great talk by Brian Heiss NCI about going beyond DLT assessment (such as looking at dose reduction frequency, duration of low grade toxicities) to evaluate dose selection for subsequent trials.

account_circle
Howard S Hochster MD(@HH_Oncodr) 's Twitter Profile Photo

State-of-the-Art Cellular therapy for solid tumors RutgersCancerInstNJ and led by Dr Christian Hinrichs for metastatic HPV associated cancers. And for KKLC1+ gastric, breast, lung and cervix . Congrats to our Cell Therapy team! Latest trials RutgersCancerInstNJ RWJBarnabas

account_circle